European Journal of Chemistry 2014, 5(4), 612-617. doi:10.5155/eurjchem.5.4.612-617.1108

FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines


Suresh Mani (1) , Mashood Ahamed Fazul Mohamed (2) , Abdul Khader Karakkakal (3) , Syed Ali Padusha Mohamed Khan (4,*)

(1) Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Autonomous), Bharathidasan University, Tiruchirappalli, 620020, Tamil Nadu, India
(2) Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Autonomous), Bharathidasan University, Tiruchirappalli, 620020, Tamil Nadu, India
(3) Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Autonomous), Bharathidasan University, Tiruchirappalli, 620020, Tamil Nadu, India
(4) Post Graduate and Research Department of Chemistry, Jamal Mohamed College (Autonomous), Bharathidasan University, Tiruchirappalli, 620020, Tamil Nadu, India
(*) Corresponding Author

Received: 11 Jun 2014, Accepted: 18 Jul 2014, Published: 31 Dec 2014

Abstract


A series of 2-hydroxypyrrolidine/piperidine derivatives (4a-h)/(4i-m) were prepared by reacting 2,3-dihydrofuran (2a)/3,4-dihydro-2H-pyran (2b) with various heterocyclic amines (3a-h), using FeCl3.6H2O as catalyst. The synthesized compounds were characterized by various physic chemical techniques such as elemental analysis and spectral analysis viz, 1H NMR, 13C NMR and Mass.


Keywords


Catalysis; Androgenic alopecia; Anti-Cholinergic drug; FeCl3-catalysed C-N coupling; 2-Hydroxypiperidine analogs; 2-Hydroxypyrrolidine analogs

Full Text:

PDF /    /


DOI: 10.5155/eurjchem.5.4.612-617.1108

Article Metrics


This Abstract was viewed 717 times | PDF Article downloaded 252 times

Citations

/


[1]. Sujit K. Ghorai, Vijaya G. Gopalsamuthiram, Anup M. Jawalekar, Rupesh E. Patre, Sitaram Pal
Iron catalyzed C N bond formation
Tetrahedron  73(14), 1769, 2017
DOI: 10.1016/j.tet.2017.02.033
/


[2]. Sergio L. Laurella, Mauricio F. Erben
Comment on “Structural and vibrational studies on 1-(5-Methyl- [1,3,4] thiadiazol-2-yl)-pyrolidin-2-ol” [Spectrochimica Acta Part A, 152 (2016) 252–261]. The importance of intramolecular OH⋯N hydrogen bonding in the conformational properties of thiadiazol-pyrrolidin-2-ol bearing species
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy  164, 40, 2016
DOI: 10.1016/j.saa.2016.03.018
/


[3]. N. Ramesh Babu, H. Saleem, S. Subashchandrabose, M. Syed Ali Padusha, S. Bharanidharan
Structural and vibrational studies on 1-(5-methyl-[1,3,4] thiadiazol-2-yl)-pyrolidin-2-ol
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy  152, 252, 2016
DOI: 10.1016/j.saa.2015.06.112
/


References

[1]. Lemos, V. A.; Santos, M. S.; Santos, E. S.; Santos, M. J. S.; Dos Santos, W. N. L.; Souza, A. S.; De Jesus, D. S.; DasVirgens, C. F.; Carvalho, M. S.; Oleszczuk, N.; Vale, M. G. R.; Welz, B.; Ferreira, S. L. C. Spectrochim. Acta B 2007, 62, 4-12.

[2]. Eleonora, D. I.; Nevena, I. P.; Rositca, D. N. Molecules 2012, 17, 4936-4949.
http://dx.doi.org/10.3390/molecules17054936

[3]. Sun, N.; Li, B.; Shao, J.; Mo, W.; Hu, B.; Shen, Z.; Hu, X. Beilstein J. Org. Chem. 2012, 8, 61-70.
http://dx.doi.org/10.3762/bjoc.8.6

[4]. Orvieto, F.; Branca, D.; Giomini, C.; Jones, P.; Koch, U.; Ontoria, J. M.; Palumbi, M. C.; Rowley, M.; Toniatti, C.; Muraglia, E. Bioorg. Med. Chem. Lett. 2009, 19, 4196-4200.
http://dx.doi.org/10.1016/j.bmcl.2009.05.113

[5]. David, G. I. K. J. Nat. Prod. 2009, 72, 507-515.
http://dx.doi.org/10.1021/np800568j

[6]. Sohl, W. E.; Shriner, R. L. J. Am. Chem. Soc. 1933, 55(9), 3828-3833.
http://dx.doi.org/10.1021/ja01336a066

[7]. Berding, G.; Gratz, K. F.; Kolbe, H.; Meyar, G. J.; Dengler, R.; Knoop, B. O.; Hundeshagen, H. Nuklearmedizin. 1994, 33, 194-199.

[8]. Ito, A.; Ohno, Y.; Nakamura, M. J. Pharmacol. Exp. Ther. 2010, 334, 171-181.
http://dx.doi.org/10.1124/jpet.110.167346

[9]. Gasparini, F.; Di Paolo, T.; Gomez-Mancilla, B. Parkinsons Dis. 2013, 2013, Article ID 196028, 11 pages.

[10]. Jakobsen, S. M.; Kersten, H.; Molden. E. J. Am. Geriatr. Soc. 2011, 59, 501-505.
http://dx.doi.org/10.1111/j.1532-5415.2010.03307.x

[11]. Imai, S.; Saito, S.; Takase, H.; Enomoto, M.; Aoyama, H.; Yamaji, S.; Yokoyama, K.; Yagi, H.; Kushiro, T.; Hirayama, T. Circ. J. 2008, 72, 709-715.
http://dx.doi.org/10.1253/circj.72.709

[12]. Nelson, M. Aust. Prescr. 2010, 33, 108-112.

[13]. Altman, D.; Granath, F.; Mattiasson, A.; Falconer, C. Int. Urogynecol. J. 2009, 20, 1285-1291.
http://dx.doi.org/10.1007/s00192-009-0957-z

[14]. Jha, S.; Parsons, M. ClinInterv Aging. 2006, 1, 309-316.
http://dx.doi.org/10.2147/ciia.2006.1.4.309

[15]. Staskin, D. R.; MacDiarmid, S. A. Am. J. Med. 2006, 119, 9-15.
http://dx.doi.org/10.1016/j.amjmed.2005.12.011

[16]. Areej, M. A. H.; Fatma, U. A.; Mutasem, O. T. J. Mol. Graphics Model. 2007, 26, 443-456.
http://dx.doi.org/10.1016/j.jmgm.2007.02.002

[17]. Liu, Y.; Zhang, J.; Xu, W. Curr. Med. Chem. 2007, 14, 2872-2891.
http://dx.doi.org/10.2174/092986707782360024

[18]. Zhang, A.; Xu, W. Mini-Rev. Med. Chem. 2006, 6, 429-448.
http://dx.doi.org/10.2174/138955706776361475

[19]. Anderson, J. M. Am. Fam. Physician. 2007, 75(6), 875-882.

[20]. Bais, J. M.; Eskes, M.; Pel, M.; Bonsel, G. J.; Bleker, O. P. Eur. J. Obstet. Gynecol. Reprod. Biol. 2004, 115, 166-172.

[21]. Magann, E. F.; Evans, S.; Chauhan, S. P.; Lanneau, G.; Fisk, A. D.; Morrison, J. C. Obstet. Gynecol. 2005, 105, 290-293.
http://dx.doi.org/10.1097/01.AOG.0000151993.83276.70

[22]. Anderson, J. M.; Etches, D. Am. Fam. Physician. 2007, 75, 875-882.

[23]. Reyes, O. A.; Gonzalez, G. M. J ObstetGynaecol Can. 2011, 33(11), 1099-1104.

[24]. Gimpl, G.; Postina, R.; Fahrenholz, F.; Reinheimer, T. Eur. J. Pharmacol. 2005, 510(1-2), 9-16.
http://dx.doi.org/10.1016/j.ejphar.2005.01.010

[25]. Osvaldo, A.; Reyes, M. D.; Geneva, M.; Gonzalez, M. D. J. Obstet. Gynaecol. Can. 2011, 33(11), 1099-1104.

[26]. Chouthaiwale, P. V.; Kotkar, S. P.; Sudalai, A. Arkivoc 2009, 2, 88-94.
http://dx.doi.org/10.3998/ark.5550190.0010.210

[27]. Dhawan, P.; Bell, A.; Kumar, A.; Golden, C.; Metha, K. D. J. Lipid Res. 1999, 40, 1911-1919.

[28]. Ahren, B.; Landin-Olsson, M.; Jansson, PA.; Svensson, M.; Holmes, D.; Schweizer, A. J. Clin. Endocrinol. Metab. 2004, 89(5), 2078-2084.
http://dx.doi.org/10.1210/jc.2003-031907

[29]. Attilakos, G.; Psaroudakis, D.; Ash, J.; Buchanan, R.; Winter, C.; Donald, F.; Hunt, L. P.; Draycotta, T. Int. J.Gynaecol. Obstet. 2010, 117(8), 929-936.
http://dx.doi.org/10.1111/j.1471-0528.2010.02585.x

[30]. Dunning, B. E.; Gerich J. E. Endocrine Rev.2007, 28, 3253-3283.
http://dx.doi.org/10.1210/er.2006-0026

[31]. Reddy, K. R.; Krishna, G. G.; Rajasekhar, C. V. Synth. Commun. 2007, 37, 4289-4299.
http://dx.doi.org/10.1080/00397910701575335

[32]. Bhanja, C.; Jena, S.; Nayak, S.; Mohapatra, S. Beilstein. J. Org. Chem. 2012, 8, 1668-1694.
http://dx.doi.org/10.3762/bjoc.8.191

[33]. Matthew, J.; Gaunt, C. C.; Johansson, A. M.; Ngoc T. V. Drug Discov. Today 2007, 12, 8-27.
http://dx.doi.org/10.1016/j.drudis.2006.11.004

[34]. Paterson, S. Br. J. Clin. Pharmacol. 1992, 33, 449-450.
http://dx.doi.org/10.1111/j.1365-2125.1992.tb04066.x

[35]. Arnsten, A. F.; Li, B. M. Biol. Psychiat. 2004, 57(11), 1377-1384.
http://dx.doi.org/10.1016/j.biopsych.2004.08.019

[36]. Kimko, H. C.; Cross, J. T.; Abernethy, D. R. Clin. Pharmacokinet. 1999, 37, 457-470.
http://dx.doi.org/10.2165/00003088-199937060-00002

[37]. Markowitz, J. S.; Devane, C. L.; Boulton, D. W.; Nahas, Z.; Risch, S. C.; Diamond, F.; Patrick, K. S. Drug Metab. Dispo. 2000, 28, 620-624.

[38]. David, H.; Kim, D. H.; Vaccaro, A. R. Spine J. 2006, 6, 479-487.
http://dx.doi.org/10.1016/j.spinee.2006.06.050

[39]. Singh, M.; Magon, N.; Singh, T. J. Midlife Health. 2013, 3, 76-80.

[40]. Report of a WHO Study Group. World Health Organ Tech. Rep. Ser. 1994, 843, 1-129.

[41]. Scow, D. T.; Nolte, R. S.; Shaughnessy, A. F. Am. Fam. Physician. 1999, 59, 2189-2194.

[42]. Balakrishnan, P.; Shanmugam, S.; Lee, W. S.; Lee, W. M.; Kim, J. O.; Oh, D. H.; Kim, D.; Kim, J. S.; Yoo, B. K.; Choi, H.; Woo, J. S.; Yong, C. S. Int. J. Pharm. 2009, 377, 1-8.
http://dx.doi.org/10.1016/j.ijpharm.2009.04.020

[43]. Varma, P. P.; Mahadevan, K. M.; Khader, A.; Hulikal, V. Org. Comm. 2011, 4(3), 52-57.


How to cite


Mani, S.; Mohamed, M.; Karakkakal, A.; Khan, S. Eur. J. Chem. 2014, 5(4), 612-617. doi:10.5155/eurjchem.5.4.612-617.1108
Mani, S.; Mohamed, M.; Karakkakal, A.; Khan, S. FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines. Eur. J. Chem. 2014, 5(4), 612-617. doi:10.5155/eurjchem.5.4.612-617.1108
Mani, S., Mohamed, M., Karakkakal, A., & Khan, S. (2014). FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines. European Journal of Chemistry, 5(4), 612-617. doi:10.5155/eurjchem.5.4.612-617.1108
Mani, Suresh, Mashood Ahamed Fazul Mohamed, Abdul Khader Karakkakal, & Syed Ali Padusha Mohamed Khan. "FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines." European Journal of Chemistry [Online], 5.4 (2014): 612-617. Web. 16 Sep. 2019
Mani, Suresh, Mohamed, Mashood, Karakkakal, Abdul, AND Khan, Syed. "FeCl3-catalysed C-N coupling reaction between cyclic ethers and heterocyclic amines" European Journal of Chemistry [Online], Volume 5 Number 4 (31 December 2014)

DOI Link: https://doi.org/10.5155/eurjchem.5.4.612-617.1108

Refbacks

  • There are currently no refbacks.




Copyright (c)




© Copyright 2019  Atlanta Publishing House LLC All Right Reserved.

The opinions expressed in all articles published in European Journal of Chemistry are those of the specific author(s), and do not necessarily reflect the views of Atlanta Publishing House LLC, or European Journal of Chemistry, or any of its employees.

Copyright 2019 Atlanta Publishing House LLC. All rights reserved. This site is owned and operated by Atlanta Publishing House LLC whose registered office is 4614 Lavista road, Tucker, GA, 30084, USA. Registered in USA.